Monday, 21 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Finance
Clinical trial results
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14455
Articles
Company
Deals
Hainan Boao Lecheng Partners with Recordati on Rare Disease Drug Development
December 14, 2024
Company
Medical Device
NMPA Approves Shanghai Magic Medicine’s Innovative Multimodal Tumor Treatment System
December 14, 2024
Company
Drug
Keymed Biosciences’ CM313 Monoclonal Antibody Shows Promise in Phase I Study for Multiple Myeloma
December 15, 2024
Company
Deals
Eccogene Secures $25 Million in Series B Financing to Advance Metabolic Disease Therapies
December 15, 2024
Company
Drug
HutchMed Presents Updated Data on Hematological Malignancy Therapies at EHA and ICML
December 15, 2024
Company
Drug
Reistone Biopharma’s Ivarmacitinib Accepted for Review by China’s CDE for Atopic Dermatitis
December 15, 2024
Company
Drug
CDE Indicates Priority Review for Overland ADCT’s Zynlonta and BeiGene’s Brukinsa
January 6, 2025
Company
Deals
Kexing Pharmaceutical Secures Commercial Rights for Convalife’s Neratinib Generic Outside China
February 12, 2025
Company
Deals
Lee’s Pharmaceutical Secures Rights to Eyedetec’s Dry Eye Device in Asia-Pacific
December 15, 2024
Company
Drug
NMPA Approves Betta Pharmaceuticals’ Vorolanib for Second-Line RCC Treatment in Combination with Everolimus
December 15, 2024
Company
Drug
Zelgen Biopharmaceuticals’ ZGGS15 Earns FDA Approval for Advanced Solid Tumor Clinical Trial
December 15, 2024
Company
Drug
CSPC Pharmaceutical’s CPO301 Receives Health Canada Approval for Phase I Study
December 15, 2024
1
2
…
955
956
957
958
959
…
1,204
1,205
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?